1. Home
  2. ACRV vs HDSN Comparison

ACRV vs HDSN Comparison

Compare ACRV & HDSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACRV
  • HDSN
  • Stock Information
  • Founded
  • ACRV 2018
  • HDSN 1991
  • Country
  • ACRV United States
  • HDSN United States
  • Employees
  • ACRV N/A
  • HDSN N/A
  • Industry
  • ACRV Medicinal Chemicals and Botanical Products
  • HDSN Industrial Specialties
  • Sector
  • ACRV Health Care
  • HDSN Consumer Discretionary
  • Exchange
  • ACRV Nasdaq
  • HDSN Nasdaq
  • Market Cap
  • ACRV 203.9M
  • HDSN 241.2M
  • IPO Year
  • ACRV 2022
  • HDSN 1994
  • Fundamental
  • Price
  • ACRV $6.60
  • HDSN $5.27
  • Analyst Decision
  • ACRV Strong Buy
  • HDSN Hold
  • Analyst Count
  • ACRV 5
  • HDSN 4
  • Target Price
  • ACRV $22.40
  • HDSN $7.31
  • AVG Volume (30 Days)
  • ACRV 63.5K
  • HDSN 644.0K
  • Earning Date
  • ACRV 11-13-2024
  • HDSN 11-04-2024
  • Dividend Yield
  • ACRV N/A
  • HDSN N/A
  • EPS Growth
  • ACRV N/A
  • HDSN N/A
  • EPS
  • ACRV N/A
  • HDSN 0.65
  • Revenue
  • ACRV N/A
  • HDSN $247,331,000.00
  • Revenue This Year
  • ACRV N/A
  • HDSN N/A
  • Revenue Next Year
  • ACRV N/A
  • HDSN N/A
  • P/E Ratio
  • ACRV N/A
  • HDSN $8.14
  • Revenue Growth
  • ACRV N/A
  • HDSN N/A
  • 52 Week Low
  • ACRV $3.19
  • HDSN $5.17
  • 52 Week High
  • ACRV $11.90
  • HDSN $15.24
  • Technical
  • Relative Strength Index (RSI)
  • ACRV 42.20
  • HDSN 29.28
  • Support Level
  • ACRV $6.56
  • HDSN $5.17
  • Resistance Level
  • ACRV $7.45
  • HDSN $6.00
  • Average True Range (ATR)
  • ACRV 0.47
  • HDSN 0.22
  • MACD
  • ACRV -0.00
  • HDSN -0.01
  • Stochastic Oscillator
  • ACRV 28.12
  • HDSN 16.84

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

About HDSN Hudson Technologies Inc.

Hudson Technologies Inc is an American industrial products manufacturer. It develops products which are mainly used in commercial air conditioning, industrial processing, and refrigeration systems. The company products include refrigerant and industrial gases, refrigerant management services and RefrigerantSide services, which consist of system decontamination. These are performed at a customer's site using its Zugibeast system, which is a fast and portable system and allows the R-Side services team to accelerate critical services while saving customers time, money and aggravation. The company also owns a web-based real-time monitoring service which is used in the facility's refrigeration systems and other energy systems.

Share on Social Networks: